Racial/ethnic and gender disparities in the use of erythropoiesis-stimulating agents and blood transfusions: cancer management under Medicare’s reimbursement policy-Reference-Cited by-同舟云学术

Racial/ethnic and gender disparities in the use of erythropoiesis-stimulating agents and blood transfusions: cancer management under Medicare’s reimbursement policy

Published:2020-11 Issue:11 Volume:26 Page:1477-1486
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Li Minghui¹,Schulz Richard²,Chisholm-Burns Marie¹,Wang Junling¹,Lu Z. Kevin²

Affiliation:

1. University of Tennessee Health Science Center College of Pharmacy, Memphis.

2. University of South Carolina College of Pharmacy, Columbia.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of a TGF‐β ligand trap (RAP‐GRL) and TMPRSS6‐ASO is superior for correcting β‐thalassemia;American Journal of Hematology;2024-04-25

2. Disparities in erythropoiesis-stimulating agent use after changes in medicare reimbursement and implementation of a risk evaluation and mitigation strategy;Drugs & Therapy Perspectives;2022-12-06

3. Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage Determination;JAMA Network Open;2021-12-09

4. Medical costs and associated racial/ethnic and sex disparities in erythropoiesis-stimulating agent use: anemia management under the Medicare reimbursement policy;Journal of Managed Care & Specialty Pharmacy;2021-08

5. A small molecule inhibitor targeting SHP2 mutations for the lung carcinoma;Chinese Chemical Letters;2021-05